✦ LIBER ✦

Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT)

✍ Scribed by H. Allain; J. Cougnard; H-C. Neukirch

Book ID: 114783548
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 525 KB
Volume: 84
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1991.tb05024.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selegiline in de novo parkinsonian patie

Selegiline in de novo parkinsonian patients: The finnish study

✍ Prof. V. V. Myllylä; K. A. Sotaniemi; J. A. Vuorinen; E. H. Heinonen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

Selegiline (L-deprenyl) has been recommended as an antiparkinsonian drug to be used as an adjunct to therapy with L-dopa, if and when L-dopa starts to lose its effect. However, initial selegiline monotherapy followed by L-dopa may be both effective and safe. A double-blind, placebo-controlled trial

Symptomatic effect of selegiline in de n

Symptomatic effect of selegiline in de novo parkinsonian patients

✍ Prof. H. Allain; P. Pollak; H. C. Neukirch 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Selegiline delays the onset of disabilit

Selegiline delays the onset of disability in de novo parkinsonian patients

✍ Palhagen, S.; Heinonen, E. H.; Hagglund, J.; Kaugesaar, T.; Kontants, H.; Maki-I 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 768 KB

Optoelectronic movement analysis in Park

Optoelectronic movement analysis in Parkinson's disease: Effect of selegiline on the disability in de novo parkinsonian patients - a pilot study

✍ B. Johnels; P. E. Ingvarsson; M. Matousek; G. Steg; E. H. Heinonen 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

SELEDO: a 5-y-ear long-term trial on the

SELEDO: a 5-y-ear long-term trial on the effect of selegiline in early parkinsonian patients treated with levodopa

✍ H. Przuntek; B. Conrad; J. Dichgans; P.H. Kraus; P. Krauseneck; G. Pergande; U. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

Combination of selegiline and controlled

Combination of selegiline and controlled release levodopa in the treatment of fluctuations of clinical disability in parkinsonian patients

✍ C. Chouza; R. Aljanati; A. Scaramelli; O. De Medina; J.L. Caamaño; R. Buzo; A. F 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB